# AMN Healthcare Services Inc: overview

AMN · NYSE · CIK 1142750 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amn.md) · [Financials](/companies/amn/financials.md) · [Filings](/companies/amn/filings.md) · [Insiders](/companies/amn/insiders.md)

Latest reported revenue: [$673.2m](/filings/0001628280-26-054507.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-054507).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [688](/filings/0001628280-25-050362.md) | [735 d](/filings/0001628280-26-009918.md) | [690](/filings/0001628280-26-032419.md) | [658](/filings/0001628280-26-054507.md) | [634](/filings/0001628280-25-050362.md) | [748 d](/filings/0001628280-26-009918.md) | [1,378](/filings/0001628280-26-032419.md) | [673](/filings/0001628280-26-054507.md) |
| Gross margin | % | [31.0%](/filings/0001628280-25-050362.md) | [29.8% d](/filings/0001628280-26-009918.md) | [28.7%](/filings/0001628280-26-032419.md) | [29.8%](/filings/0001628280-26-054507.md) | [29.1%](/filings/0001628280-25-050362.md) | [26.1% d](/filings/0001628280-26-009918.md) | [26.8%](/filings/0001628280-26-032419.md) | [30.6%](/filings/0001628280-26-054507.md) |
| Operating margin | % | [3.2%](/filings/0001628280-25-050362.md) | [(27.6%) d](/filings/0001628280-26-009918.md) | [1.8%](/filings/0001628280-26-032419.md) | [(18.8%)](/filings/0001628280-26-054507.md) | [7.5%](/filings/0001628280-25-050362.md) | [1.1% d](/filings/0001628280-26-009918.md) | [8.5%](/filings/0001628280-26-032419.md) | [4.0%](/filings/0001628280-26-054507.md) |
| Net margin | % | [1.0%](/filings/0001628280-25-050362.md) | [(25.5%) d](/filings/0001628280-26-009918.md) | [(0.2%)](/filings/0001628280-26-032419.md) | [(17.7%)](/filings/0001628280-26-054507.md) | [4.6%](/filings/0001628280-25-050362.md) | [(1.0%) d](/filings/0001628280-26-009918.md) | [4.5%](/filings/0001628280-26-032419.md) | [3.1%](/filings/0001628280-26-054507.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001628280-25-050362.md) | not reported | [(0.03)](/filings/0001628280-26-032419.md) | [(3.02)](/filings/0001628280-26-054507.md) | [0.76](/filings/0001628280-25-050362.md) | not reported | [1.59](/filings/0001628280-26-032419.md) | [0.53](/filings/0001628280-26-054507.md) |
| Free cash flow | $m | [47.4 d](/filings/0001628280-25-050362.md) | [56.6 d](/filings/0001628280-26-009918.md) | [82.7](/filings/0001628280-26-032419.md) | [68.7 d](/filings/0001628280-26-054507.md) | [14.8 d](/filings/0001628280-25-050362.md) | [67.6 d](/filings/0001628280-26-009918.md) | [555](/filings/0001628280-26-032419.md) | [(198) d](/filings/0001628280-26-054507.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,984](/filings/0001142750-24-000016.md) | [5,243](/filings/0001142750-25-000011.md) | [3,789](/filings/0001628280-26-009918.md) | [2,984](/filings/0001628280-26-009918.md) | [2,730](/filings/0001628280-26-009918.md) |
| Gross margin | % | [32.9%](/filings/0001142750-24-000016.md) | [32.7%](/filings/0001142750-25-000011.md) | [33.0%](/filings/0001628280-26-009918.md) | [30.8%](/filings/0001628280-26-009918.md) | [28.3%](/filings/0001628280-26-009918.md) |
| Operating margin | % | [12.0%](/filings/0001142750-24-000016.md) | [12.3%](/filings/0001142750-25-000011.md) | [8.9%](/filings/0001628280-26-009918.md) | [(3.4%)](/filings/0001628280-26-009918.md) | [(2.0%)](/filings/0001628280-26-009918.md) |
| Net margin | % | [8.2%](/filings/0001142750-24-000016.md) | [8.5%](/filings/0001142750-25-000011.md) | [5.6%](/filings/0001628280-26-009918.md) | [(4.9%)](/filings/0001628280-26-009918.md) | [(3.5%)](/filings/0001628280-26-009918.md) |
| Diluted EPS | $ per share | [6.81](/filings/0001142750-24-000016.md) | [9.90](/filings/0001142750-25-000011.md) | [5.36](/filings/0001628280-26-009918.md) | [(3.85)](/filings/0001628280-26-009918.md) | [(2.48)](/filings/0001628280-26-009918.md) |
| Free cash flow | $m | [252](/filings/0001142750-24-000016.md) | [578](/filings/0001142750-25-000011.md) | [268](/filings/0001628280-26-009918.md) | [240](/filings/0001628280-26-009918.md) | [234](/filings/0001628280-26-009918.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/amn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $215.0m | 6,643,401 |  | Added +619,906 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $73.9m | 2,282,597 |  | Added +941,922 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $55.6m | 1,719,045 |  | Added +41,619 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $54.8m | 1,694,316 |  | Added +79,912 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $54.2m | 1,674,561 |  | Reduced −463,827 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $45.1m | 1,391,859 |  | Reduced −9,866 |
| [Allianz Asset Management GmbH](/funds/1535323.md) | 2026-06-30 | $44.0m | 1,402,948 |  | Added +141,944 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $41.7m | 1,288,073 |  | Added +163,404 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $41.5m | 1,283,381 |  | Added +542,172 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $37.5m | 1,158,258 |  | Reduced −429,423 |

## Recent filings

[All 1,075 filings](/companies/amn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 18:10 ET | [10-Q](/filings/0001628280-26-054507.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054507 |
| 2026-08-06 | 16:17 ET | [8-K](/filings/0001142750-26-000008.md) | 9.01 Financial statements and exhibits | 0001142750-26-000008 |
| 2026-05-08 | 18:08 ET | [10-Q](/filings/0001628280-26-032419.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032419 |
| 2026-05-07 | 16:20 ET | [8-K](/filings/0001142750-26-000007.md) | 9.01 Financial statements and exhibits | 0001142750-26-000007 |
| 2026-05-04 | 08:00 ET | [8-K](/filings/0001104659-26-054478.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-054478 |
| 2026-03-18 | 08:00 ET | [DEF 14A](/filings/0001104659-26-029908.md) | Proxy statement, period 2026-05-01 | 0001104659-26-029908 |
| 2026-02-20 | 18:15 ET | [10-K](/filings/0001628280-26-009918.md) | Annual report, period 2025-12-31 | 0001628280-26-009918 |
| 2026-02-19 | 16:15 ET | [8-K](/filings/0001142750-26-000003.md) | 9.01 Financial statements and exhibits | 0001142750-26-000003 |
| 2026-02-05 | 09:24 ET | [8-K](/filings/0000950142-26-000299.md) | 5.02 Departure or appointment of officers or directors | 0000950142-26-000299 |
| 2026-01-14 | 09:01 ET | [8-K](/filings/0001142750-26-000001.md) | 7.01 Regulation FD disclosure | 0001142750-26-000001 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-009918.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/60ef3656-7985-4bbb-bf81-1418bff31918)

## About the filer

- CIK: 1142750
- Tickers: AMN
- Exchange: NYSE
- SIC code: 7363 Services-Help Supply Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.